Temat: "Salvage Therapy" - OpacWWW

Skocz do pozycji: 41.

Tytuł:: Impact of geniohyoid and masseter muscle masses on dysphagia after salvage surgery and radiotherapy in head and neck cancer.
Autorzy:: Hashida N; Department of Rehabilitation, Osaka International Cancer Institute, Osaka City, Japan.
Shamoto H; Takano Hospital, Futaba-County, Fukushima, Japan.; Department of Disaster and Comprehensive Medicine, Fukushima Medical University, Fukushima City, Fukushima, Japan.
Maeda K; Department of Geriatric Medicine, National Center for Geriatrics and Gerontology, 7-430 Morioka, Obu, Aichi, 474-8511, Japan. .
Wakabayashi H; Department of Rehabilitation Medicine, Tokyo Women's Medical University Hospital, Tokyo, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Jan 26; Vol. 11 (1), pp. 2278. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Salvage Therapy*
Deglutition Disorders/*etiology
Head and Neck Neoplasms/*radiotherapy
Head and Neck Neoplasms/*surgery
Masseter Muscle/*pathology
Aged ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 42.

Tytuł:: Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial.
Autorzy:: Firouzabadi D; Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Dehghanian A; Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; Molecular Pathology and Cytogenetics Section, Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Rezvani A; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. .; Hematology and Medical Oncology Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .
Mahmoudi L; Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. mahmoudi_.
Talei A; Breast Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Jan 11; Vol. 21 (1), pp. 47. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji:: Journal Article; Randomized Controlled Trial
MeSH Terms:: Salvage Therapy*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Neoadjuvant Therapy/*methods
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/pathology ; Carboplatin/administration & dosage ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Female ; Follow-Up Studies ; Humans ; Middle Aged ; Prognosis ; Prospective Studies ; Young Adult ; Gemcitabine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 43.

Tytuł:: Sorafenib as a second-line treatment in metastatic renal cell carcinoma in Mexico: a prospective cohort study.
Autorzy:: Martín-Aguilar AE; Centro Médico Nacional Siglo XXI, Av. Cuauhtémoc 330, Doctores, Cuauhtémoc, 06720 Ciudad de México, CDMX, Mexico City, Mexico.
Núñez-López H; Centro Médico Nacional Siglo XXI, Av. Cuauhtémoc 330, Doctores, Cuauhtémoc, 06720 Ciudad de México, CDMX, Mexico City, Mexico.
Ramirez-Sandoval JC; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Belisario Dominguez Sección XVI, 14080, Mexico City, PC, Mexico. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2021 Jan 05; Vol. 21 (1), pp. 16. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Salvage Therapy*
Antineoplastic Agents/*therapeutic use
Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Sunitinib/*therapeutic use
Aged ; Carcinoma, Renal Cell/secondary ; Female ; Follow-Up Studies ; Humans ; Kidney Neoplasms/pathology ; Male ; Mexico ; Middle Aged ; Prognosis ; Prospective Studies ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 44.

Tytuł:: Open-Label, phase 2 study of blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.
Autorzy:: Coyle L; Department of Haematology, Royal North Shore Hospital, St. Leonards, Australia.
Morley NJ; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Rambaldi A; Department of Oncology-Hematology, University of Milan and Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Mason KD; Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, Australia.
Verhoef G; Department of Hematology, UZ Leuven, University Hospitals Leuven, Leuven, Belgium.
Furness CL; Department of Paediatric Haemato-Oncology, Royal Marsden NHS Foundation Trust, London, UK.
Zhang A; Global Biostatistical Science, Amgen Inc, Thousand Oaks, CA, USA.
Jung AS; Global Development, Amgen Inc, Thousand Oaks, CA, USA.
Cohan D; Global Development, Amgen Inc, Thousand Oaks, CA, USA.
Franklin JL; Global Development, Amgen Inc, Thousand Oaks, CA, USA.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2020 Sep; Vol. 61 (9), pp. 2103-2112. Date of Electronic Publication: 2020 Jun 16.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Lymphoma, Non-Hodgkin*/drug therapy
Salvage Therapy*
Adult ; Antibodies, Bispecific ; Antineoplastic Combined Chemotherapy Protocols ; B-Lymphocytes ; Humans ; Neoplasm Recurrence, Local

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 45.

Tytuł:: Local control by salvage stereotactic body radiotherapy for recurrent/residual hepatocellular carcinoma after other local therapies.
Autorzy:: Kibe Y; Radiation Oncology Center, Ofuna Chuo Hospital, Kamakura, Japan.
Takeda A; Radiation Oncology Center, Ofuna Chuo Hospital, Kamakura, Japan.
Tsurugai Y; Radiation Oncology Center, Ofuna Chuo Hospital, Kamakura, Japan.
Eriguchi T; Radiation Oncology Center, Ofuna Chuo Hospital, Kamakura, Japan.; Department of Radiation Oncology, Saiseikai Yokohamashi Tobu Hospital, Yokohama, Japan.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2020 Aug; Vol. 59 (8), pp. 888-894. Date of Electronic Publication: 2020 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: Radiosurgery*/adverse effects
Radiosurgery*/mortality
Carcinoma, Hepatocellular/*radiotherapy
Liver Neoplasms/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Salvage Therapy/*methods
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/therapy ; Chemoembolization, Therapeutic/mortality ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms/mortality ; Liver Neoplasms/pathology ; Liver Neoplasms/therapy ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; Neoplasm, Residual ; Retrospective Studies ; Risk Factors ; Salvage Therapy/adverse effects ; Salvage Therapy/mortality ; Time Factors ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 46.

Tytuł:: Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway.
Autorzy:: Wang H; Department of Hematology, Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Liu YC; Department of Hematology, Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Zhu CY; Department of Hematology, Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Yan F; State Key Laboratory of Inorganic Synthesis and Preparative Chemistry, International Joint Research Laboratory of Nano-Micro Architecture Chemistry (NMAC), International Research Center for Chemistry-Medicine Joint Innovation, College of Chemistry, Jilin University, 2699 Qianjin Street, Changchun, 130012, China.
Wang MZ; Department of Hematology, Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Chen XS; School of Medicine, Nankai University, 94 Weijin Road, Tianjin, 300071, China.
Wang XK; Department of Orthopedics, Xiqing Hospital, 403 Xiqing Road, Yangliuqing, Tianjin, 300000, China.
Pang BX; Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands.
Li YH; Department of Hematology, Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Beijing, 100853, China.
Liu DH; Department of Hematology, Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Beijing, 100853, China. .
Gao CJ; Department of Hematology, Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Beijing, 100853, China. .
Liu SJ; The Hormel Institute, University of Minnesota, 801 16th Avenue NE, Austin, MN, 55912, USA. .
Dou LP; Department of Hematology, Chinese People's Liberation Army (PLA) General Hospital, 28 Fuxing Road, Beijing, 100853, China. .; Pokaż więcej
Źródło:: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2020 Dec 09; Vol. 39 (1), pp. 278. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Resistance, Neoplasm*
Salvage Therapy*
Antineoplastic Combined Chemotherapy Protocols/*pharmacology
Biomarkers, Tumor/*metabolism
Gene Expression Regulation, Neoplastic/*drug effects
Leukemia, Myeloid, Acute/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Adolescent ; Adult ; Aged ; Aminopyridines/administration & dosage ; Animals ; Anthracyclines/administration & dosage ; Apoptosis ; Benzamides/administration & dosage ; Biomarkers, Tumor/genetics ; Cell Cycle ; Cell Proliferation ; Child ; Cyclin-Dependent Kinase 2/genetics ; Cyclin-Dependent Kinase 2/metabolism ; Cyclin-Dependent Kinase Inhibitor p21/genetics ; Cyclin-Dependent Kinase Inhibitor p21/metabolism ; Female ; Histone Deacetylases/genetics ; Histone Deacetylases/metabolism ; Humans ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/metabolism ; Leukemia, Myeloid, Acute/pathology ; Male ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Middle Aged ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/metabolism ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; Survival Rate ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 47.

Tytuł:: Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results.
Autorzy:: Ueno M; Kanagawa Cancer Centre Hospital, Yokohama, Japan.
Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, 277-8577, Japan. .
Sasaki T; Cancer Institute Hospital of JFCR, Tokyo, Japan.
Nagashima F; Kyorin University, Tokyo, Japan.
Mizuno N; Aichi Cancer Centre Hospital, Nagoya, Japan.
Shimizu S; Saitama Cancer Centre, Saitama, Japan.
Ikezawa H; Eisai Co. Ltd., Tokyo, Japan.
Hayata N; Eisai Co. Ltd., Tokyo, Japan.
Nakajima R; Eisai Inc., Woodcliff Lake, NJ, USA.
Morizane C; National Cancer Centre Hospital, Tokyo, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2020 Nov 16; Vol. 20 (1), pp. 1105. Date of Electronic Publication: 2020 Nov 16.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Multicenter Study
MeSH Terms:: Salvage Therapy*
Antineoplastic Agents/*therapeutic use
Biliary Tract Neoplasms/*drug therapy
Phenylurea Compounds/*therapeutic use
Quinolines/*therapeutic use
Adult ; Aged ; Biliary Tract Neoplasms/pathology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 48.

Tytuł:: Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective.
Autorzy:: Sureda A; Hematology Department, Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia-Hospital Duran i Reynals, Gran Via de l'Hospitalet, 199 - 203, 08908, Barcelona, Spain. .; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona (UB), Barcelona, Spain. .
André M; Department of Hematology, Université catholique de Louvain, CHU UCL Namur, Yvoir, Belgium.
Borchmann P; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
da Silva MG; Department of Hematology, Instituto Português de Oncologia - Francisco Gentil, Lisbon, Portugal.
Gisselbrecht C; Institut d'Hématologie, Hôpital Saint Louis, Paris, France.
Vassilakopoulos TP; Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece.
Zinzani PL; Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.; Istituto di Ematologia 'Seràgnoli', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università degli Studi, Bologna, Italy.
Walewski J; Department of Lymphoid Malignancies, Maria Sklodowska-Curie Institute Oncology Center, Warszawa, Poland.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2020 Nov 10; Vol. 20 (1), pp. 1088. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Drug Resistance, Neoplasm*
Salvage Therapy*
Antineoplastic Agents/*therapeutic use
Hematopoietic Stem Cell Transplantation/*mortality
Hodgkin Disease/*mortality
Neoplasm Recurrence, Local/*mortality
Hodgkin Disease/drug therapy ; Hodgkin Disease/pathology ; Humans ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Survival Rate ; Transplantation, Autologous

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 49.

Tytuł:: How can we best manage biochemical failure after radical prostatectomy?
Autorzy:: Kim WT; Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea.
Kim J; Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
Kim WJ; Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea.; Institute of Urotech, Cheongju, Korea. .; Pokaż więcej
Źródło:: Investigative and clinical urology [Investig Clin Urol] 2022 Nov; Vol. 63 (6), pp. 592-601.
Typ publikacji:: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Prostate*
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/radiotherapy
Male ; Humans ; Androgen Antagonists/therapeutic use ; Neoplasm Recurrence, Local/surgery ; Prostatectomy/adverse effects ; Prostatectomy/methods ; Prostate-Specific Antigen ; Salvage Therapy/methods ; Disease Progression ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 50.

Tytuł:: Point-of-care CAR T-cell therapy as salvage strategy for out-of-specification tisagenlecleucel.
Autorzy:: Fried, Shalev (AUTHOR)
Shouval, Roni (AUTHOR)
Varda-Bloom, Nira (AUTHOR)
Besser, Michal J. (AUTHOR)
Yerushalmi, Ronit (AUTHOR)
Shem-Tov, Noga (AUTHOR)
Danylesko, Ivetta (AUTHOR)
Jacoby, Elad (AUTHOR)
Teihman, Shlomit (AUTHOR)
Itzhaki, Orit (AUTHOR)
Fein, Joshua A. (AUTHOR)
Kedmi, Meirav (AUTHOR)
Shimoni, Avichai (AUTHOR)
Nagler, Arnon (AUTHOR)
Avigdor, Abraham (AUTHOR); Pokaż więcej
Źródło:: Leukemia & Lymphoma. Dec2022, Vol. 63 Issue 14, p3385-3393. 9p.

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 51.

Tytuł:: Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study.
Autorzy:: Ito M; Department of Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan. .
Kodaira T; Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 484-8681, Japan.
Koide Y; Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 484-8681, Japan.
Okuda T; Department of Radiation Oncology, Toyota Memorial Hospital, 1-1-1 Heiwa-cho, Toyota, Aichi, 471-8513, Japan.
Mizumatsu S; Department of CyberKnife Center, Aoyama Hospital, 100-1 Kozakai-tyo-doji, Toyokawa, Aichi, 441-0195, Japan.
Oshima Y; Department of Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.
Takeuchi A; Department of Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.
Mori T; Department of Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.
Abe S; Department of Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.; Department of Radiation Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 484-8681, Japan.
Asai A; Department of Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.
Suzuki K; Department of Radiology, Aichi Medical University Hospital, 1-1 Yazako-Karimata, Nagakute, Aichi, 480-1195, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2020 Jun 09; Vol. 20 (1), pp. 540. Date of Electronic Publication: 2020 Jun 09.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Lymphatic Metastasis/*radiotherapy
Salvage Therapy/*methods
Abdomen ; Adult ; Aged ; Aged, 80 and over ; Colorectal Neoplasms/pathology ; Endometrial Neoplasms/pathology ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Ovarian Neoplasms/pathology ; Pelvis ; Progression-Free Survival ; Proportional Hazards Models ; Prospective Studies ; Radiosurgery/instrumentation ; Radiosurgery/methods ; Radiosurgery/mortality ; Radiotherapy Dosage ; Retrospective Studies ; Salvage Therapy/adverse effects ; Salvage Therapy/mortality ; Treatment Outcome ; Uterine Cervical Neoplasms/pathology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 52.

Tytuł:: Salvage surgery for stage IVa thymic carcinoma combined with aortic arch resection - case report.
Autorzy:: Yamato H; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Funaki S; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Shimamura K; Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Kin K; Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Kuratani T; Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Sawa Y; Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Shintani Y; Department of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan. .; Pokaż więcej
Źródło:: Journal of cardiothoracic surgery [J Cardiothorac Surg] 2020 Oct 07; Vol. 15 (1), pp. 305. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Pneumonectomy*
Salvage Therapy*
Aorta, Thoracic/*surgery
Thymoma/*surgery
Thymus Neoplasms/*surgery
Humans ; Male ; Middle Aged ; Postoperative Period ; Prognosis ; Tomography, X-Ray Computed ; Vascular Surgical Procedures

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 53.

Tytuł:: Use of Letermovir for Salvage Therapy for Resistant Cytomegalovirus in a Pediatric Hematopoietic Stem Cell Transplant Recipient.
Autorzy:: Kilgore JT; Division of Pediatric Infectious Diseases, Duke University, Durham, North Carolina.
Becken B; Division of Pediatric Infectious Diseases, Duke University, Durham, North Carolina.
Varga MG; Department of Epidemiology, Gillings School of Global Public Health and the Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina.
Parikh S; Pediatric Bone Marrow Transplant Program, Duke University, Durham, North Carolina.
Prasad V; Pediatric Bone Marrow Transplant Program, Duke University, Durham, North Carolina.
Lugo D; Division of Pediatric Infectious Diseases, Duke University, Durham, North Carolina.; Pediatric Immunocompromised Host Program, Duke University, Durham, North Carolina.
Chang YC; Division of Pediatric Infectious Diseases, Duke University, Durham, North Carolina.; Pediatric Immunocompromised Host Program, Duke University, Durham, North Carolina.; Pokaż więcej
Źródło:: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2020 Sep 17; Vol. 9 (4), pp. 486-489.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Salvage Therapy*
Acetates/*therapeutic use
Antiviral Agents/*therapeutic use
Cytomegalovirus Infections/*drug therapy
Quinazolines/*therapeutic use
Adolescent ; Drug Resistance, Viral ; Female ; Humans ; Immunocompromised Host

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 54.

Tytuł:: Bridge to heart transplantation using the Levitronix CentriMag short-term ventricular assist device.
Autorzy:: Sef D; Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, London, UK.
Mohite P; Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, London, UK.
De Robertis F; Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, London, UK.
Verzelloni Sef A; Department of Anesthesia and Critical Care, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, London, UK.
Mahesh B; Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, London, UK.
Stock U; Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, London, UK.
Simon A; Department of Cardiothoracic Transplantation and Mechanical Circulatory Support, Royal Brompton and Harefield NHS Foundation Trust, Harefield Hospital, London, UK.; Pokaż więcej
Źródło:: Artificial organs [Artif Organs] 2020 Sep; Vol. 44 (9), pp. 1006-1008. Date of Electronic Publication: 2020 May 05.
Typ publikacji:: Letter
MeSH Terms:: Cardiomyopathy, Dilated/*surgery
Heart Failure/*surgery
Heart Transplantation/*statistics & numerical data
Heart-Assist Devices/*statistics & numerical data
Salvage Therapy/*methods
Adult ; Cardiomyopathy, Dilated/complications ; Cardiomyopathy, Dilated/mortality ; Critical Illness/mortality ; Critical Illness/therapy ; Female ; Heart Failure/etiology ; Heart Failure/mortality ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Salvage Therapy/statistics & numerical data ; Time Factors ; Treatment Outcome ; Young Adult

Opinia redakcyjna

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 55.

Tytuł:: Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma.
Autorzy:: Yu X; Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China.
Li X; Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China.
Xing Y; Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China.
Lu S; Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China.
Tanumiharjo S; Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China.
Ma J; Zhongshan Ophthalmic Center, State Key Laboratory of Ophthalmology, Sun Yat-sen University, Guangzhou, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2020 Aug 26; Vol. 20 (1), pp. 808. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji:: Journal Article
MeSH Terms:: Neoplasm Recurrence, Local/*epidemiology
Retinal Neoplasms/*therapy
Retinoblastoma/*therapy
Salvage Therapy/*methods
Topotecan/*administration & dosage
Vitrectomy/*methods
Chemotherapy, Adjuvant/adverse effects ; Chemotherapy, Adjuvant/methods ; Child ; Child, Preschool ; Follow-Up Studies ; Humans ; Infant ; Intravitreal Injections ; Neoadjuvant Therapy/adverse effects ; Neoadjuvant Therapy/methods ; Neoplasm Recurrence, Local/prevention & control ; Neoplasm Seeding ; Retinal Neoplasms/pathology ; Retinoblastoma/pathology ; Retrospective Studies ; Salvage Therapy/adverse effects ; Topotecan/adverse effects ; Treatment Outcome ; Visual Acuity ; Vitrectomy/adverse effects ; Vitreous Body/drug effects ; Vitreous Body/pathology ; Vitreous Body/surgery

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 56.

Tytuł:: Impact of salvage treatment phase on inotuzumab ozogamicin treatment for relapsed/refractory acute lymphoblastic leukemia: an update from the INO-VATE final study database.
Autorzy:: Jabbour E; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Stelljes M; Department of Medicine, Hematology and Oncology, Universitätsklinikum Münster, Münster, Germany.
Advani AS; Department of Hematology/Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Gökbuget N; Department of Medicine II, University Hospital, Goethe University, Frankfurt, Germany.
Marks DI; Bristol Haematology & Oncology Centre, University Hospitals Bristol NHS Trust, Bristol, UK.
Stock W; Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
O'Brien S; Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA, USA.
Cassaday RD; Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Wang T; Global Product Development - Oncology, Pfizer Inc, Cambridge, MA, USA.
Neuhof A; Pfizer Pharma GmbH, Berlin, Germany.
Vandendries E; Global Product Development - Oncology, Pfizer Inc, Cambridge, MA, USA.
Kantarjian H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pokaż więcej
Źródło:: Leukemia & lymphoma [Leuk Lymphoma] 2020 Aug; Vol. 61 (8), pp. 2012-2015. Date of Electronic Publication: 2020 May 07.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Salvage Therapy*
Humans ; Inotuzumab Ozogamicin ; Remission Induction

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 57.

Tytuł:: Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer.
Autorzy:: Kawai S; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan. .
Fukuda N; Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation For Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.
Yamamoto S; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Mitani S; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan.
Omae K; Clinical Research Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.
Wakatsuki T; Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation For Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.
Kato K; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan.
Takahari D; Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation For Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.
Boku N; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, 464-8681, Japan.
Machida N; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2020 Apr 21; Vol. 20 (1), pp. 338. Date of Electronic Publication: 2020 Apr 21.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Salvage Therapy*
Adenocarcinoma/*drug therapy
Antibodies, Monoclonal, Humanized/*therapeutic use
Antineoplastic Agents/*therapeutic use
Esophagogastric Junction/*drug effects
Stomach Neoplasms/*drug therapy
Adenocarcinoma/pathology ; Adult ; Aged ; Aged, 80 and over ; Esophagogastric Junction/pathology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Stomach Neoplasms/pathology ; Survival Rate ; Ramucirumab

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 58.

Tytuł:: A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol).
Autorzy:: Oashi K; Department of Dermatology, Saitama Cancer Center, 780 Komuro, Ina, Kita-adachi-gun, Saitama, 362-0806, Japan. .
Shibata T; JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Namikawa K; Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Takahashi A; Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yokota K; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nakano E; Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Teramoto Y; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
Tsutsumida A; Department of Dermatologic Oncology, Dermatology, Cancer Institute Hospital, Tokyo, Japan.
Maeda T; Department of Plastic and Reconstructive Surgery, Faculty of Medicine and Graduate School of Medicine Hokkaido University, Sapporo, Japan.
Yamazaki N; Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Pokaż więcej
Corporate Authors:: Dermatologic Oncology Group of the Japan Clinical Oncology Group
Źródło:: BMC cancer [BMC Cancer] 2020 Jul 13; Vol. 20 (1), pp. 652. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji:: Journal Article
MeSH Terms:: Salvage Therapy*
Antineoplastic Agents, Phytogenic/*therapeutic use
Drug Resistance, Neoplasm/*drug effects
Hemangiosarcoma/*drug therapy
Paclitaxel/*pharmacology
Pyrimidines/*therapeutic use
Skin Neoplasms/*drug therapy
Sulfonamides/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Hemangiosarcoma/pathology ; Humans ; Indazoles ; Male ; Middle Aged ; Prognosis ; Research Design ; Skin Neoplasms/pathology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 59.

Tytuł:: Stereotactic irradiation of non-small cell lung cancer brain metastases: evaluation of local and cerebral control in a large series.
Autorzy:: Fessart E; Academic Department of Radiation Oncology, Centre Oscar Lambret, 59020, Lille Cedex, France.
Mouttet Audouard R; Academic Department of Radiation Oncology, Centre Oscar Lambret, 59020, Lille Cedex, France.
Le Tinier F; Academic Department of Radiation Oncology, Centre Oscar Lambret, 59020, Lille Cedex, France.
Coche-Dequeant B; Academic Department of Radiation Oncology, Centre Oscar Lambret, 59020, Lille Cedex, France.
Lacornerie T; Academic Department of Radiation Oncology, Centre Oscar Lambret, 59020, Lille Cedex, France.
Tresch E; Department of Biostatistics, Centre Oscar Lambret, Lille, France.
Scherpereel A; Department of Pulmonary and Thoracic Oncology, University of Lille, University Hospital (CHU), Lille, France.
Lartigau E; Academic Department of Radiation Oncology, Centre Oscar Lambret, 59020, Lille Cedex, France.; CRISTAL UMR CNRS 9189, Lille University, Lille, France.
Mirabel X; Academic Department of Radiation Oncology, Centre Oscar Lambret, 59020, Lille Cedex, France.
Pasquier D; Academic Department of Radiation Oncology, Centre Oscar Lambret, 59020, Lille Cedex, France. .; CRISTAL UMR CNRS 9189, Lille University, Lille, France. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Jul 08; Vol. 10 (1), pp. 11201. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji:: Journal Article
MeSH Terms:: Brain Neoplasms/*radiotherapy
Carcinoma, Non-Small-Cell Lung/*radiotherapy
Cranial Irradiation/*methods
Lung Neoplasms/*pathology
Radiosurgery/*methods
Salvage Therapy/*methods
Aged ; Brain/diagnostic imaging ; Brain/pathology ; Brain/radiation effects ; Brain Neoplasms/mortality ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/secondary ; Cranial Irradiation/adverse effects ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Karnofsky Performance Status ; Lung Neoplasms/mortality ; Lung Neoplasms/radiotherapy ; Male ; Middle Aged ; Radiation Dose Hypofractionation ; Radiosurgery/adverse effects ; Response Evaluation Criteria in Solid Tumors ; Retrospective Studies ; Salvage Therapy/adverse effects ; Survival Rate ; Tumor Burden

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 60.

Tytuł:: Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study.
Autorzy:: Ikeda T; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Takemoto S; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Senju H; Department of Respiratory Medicine, Sasebo City General Hospital, Sasebo, Japan.
Gyotoku H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Taniguchi H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Molecular Pharmacology Program and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Shimada M; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Respiratory Medicine, Sasebo City General Hospital, Sasebo, Japan.
Dotsu Y; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Umeyama Y; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Tomono H; Department of Respiratory Medicine, Sasebo City General Hospital, Sasebo, Japan.; Department of Medicine, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
Kitazaki T; Department of Respiratory Medicine, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
Fukuda M; Department of Respiratory Medicine, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
Soda H; Department of Respiratory Medicine, Sasebo City General Hospital, Sasebo, Japan.
Yamaguchi H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Fukuda M; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Clinical Oncology Center, Nagasaki University Hospital, Nagasaki, Japan.
Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2020 Jul; Vol. 11 (7), pp. 1972-1978. Date of Electronic Publication: 2020 May 28.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Multicenter Study
MeSH Terms:: Salvage Therapy*
Anthracyclines/*therapeutic use
Antineoplastic Agents/*therapeutic use
Mesothelioma, Malignant/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Pleural Neoplasms/*drug therapy
Aged ; Female ; Follow-Up Studies ; Humans ; Male ; Mesothelioma, Malignant/pathology ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Pleural Neoplasms/pathology ; Prognosis ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Salvage Therapy"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji